Rodgers Brothers’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-27,837
Closed -$2.51M 236
2024
Q3
$2.51M Hold
27,837
0.32% 90
2024
Q2
$2.19M Hold
27,837
0.3% 95
2024
Q1
$2.43M Buy
27,837
+11,383
+69% +$971K 0.33% 87
2023
Q4
$1.36M Sell
16,454
-8,300
-34% -$633K 0.21% 104
2023
Q3
$1.94M Buy
24,754
+1,189
+5% +$99.5K 0.33% 82
2023
Q2
$2.08M Sell
23,565
-39
-0.2% -$3.36K 0.37% 78
2023
Q1
$1.9M Buy
23,604
+12,050
+104% +$982K 0.37% 74
2022
Q4
$898K Sell
11,554
-10,375
-47% -$841K 0.18% 113
2022
Q3
$1.77M Sell
21,929
-350
-2% -$31.5K 0.38% 75
2022
Q2
$2M Buy
22,279
+10,100
+83% +$1.02M 0.4% 73
2022
Q1
$1.35M Sell
12,179
-11
-0.1% -$1.16K 0.24% 98
2021
Q4
$1.26M Sell
12,190
-800
-6% -$92.6K 0.22% 103
2021
Q3
$1.63M Hold
12,990
0.32% 81
2021
Q2
$1.61M Buy
12,990
+28
+0.2% +$3.52K 0.31% 85
2021
Q1
$1.53M Hold
12,962
0.32% 84
2020
Q4
$1.52M Sell
12,962
-150
-1% -$16.5K 0.35% 77
2020
Q3
$1.36M Sell
13,112
-1,250
-9% -$126K 0.35% 77
2020
Q2
$1.32M Buy
+14,362
New +$1.38M 0.36% 72

Other funds holding MDT

Rodgers Brothers's MDT Position: Q4 2024 in Review

Rodgers Brothers sold out of Medtronic (MDT) in Q4 2024, closing a stake of 27,837 shares — an estimated $2.51M sold.

Rodgers Brothers first reported a position in MDT in Q2 2020 and held it in 18 quarters. The position peaked at $2.51M in Q3 2024. 2,130 funds tracked by Wall St. Rank hold MDT as of Q4 2024.

  • Rodgers Brothers reported no remaining Medtronic position as of Q4 2024 after selling out during the quarter.
  • Rodgers Brothers sold 27,837 Medtronic shares in Q4 2024, an estimated $2.51M.
  • Rodgers Brothers first reported a position in Medtronic in Q2 2020 and held it in 18 quarters.
  • Rodgers Brothers's Medtronic position peaked at $2.51M in Q3 2024.
  • 2,130 funds tracked by Wall St. Rank held Medtronic as of Q4 2024.

Based on Rodgers Brothers's 13F filing for Q4 2024, filed 12 Feb 2025.